RECORDING: Professionals’ Conference – 19 September 2025
A recording of the Retina UK Professionals' Conference on 19 September 2025. The Conference was held at the Holiday Inn, Regent's Park, London and online.
Search
Search results
Webinar: Ask the expert with Professor Marcela Votruba
Join us for our upcoming webinar!
Podcast: Meet the professionals – Genetic Counsellor
The latest podcast from Retina UK.
Meet our Trustee: Rob Halliwell
Rob is a Chief Technology Officer based in Manchester, with over 20 years’ experience leading technology, software development and digital transformation.
SparingVision completes dosing in PRODYGY trial of SPVNO6 for retinitis pigmentosa.
SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).
Atsena Therapeutics present positive clinical data for LCA1 gene therapy program
Astena Theraputics' investigational gene therapy, ATSN-101, has shown promising long-term results in an early clinical trial for LCA1, a sever inherited retinal disease caused by mutations in the GUCY2D gene.
Fundraising
Raise money to help support people affected by inherited sight loss to lead better lives today and accelerate the search for treatments for the future.
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Frequently asked questions
The following questions are often asked by people contacting Retina UK.